Perspective on Corticosteroid Use and Interleukin-1 Inhibition With Anakinra in Pericarditis During Pregnancy. [PDF]
Trotta L +3 more
europepmc +1 more source
Acute interleukin-1β antagonism decreases systemic inflammation, increases GLP-1 release, and modulates insulin secretion in individuals with prediabetes. [PDF]
Fischer JS +5 more
europepmc +1 more source
Reply: Perspective on Corticosteroid Use and Interleukin-1 Inhibition With Anakinra in Pericarditis During Pregnancy. [PDF]
Schmitz KT +4 more
europepmc +1 more source
Targeted innate immune inhibition therapy compared with antibiotics for recurrent acute cystitis: a randomized, open-label phase 2 trial. [PDF]
Ambite I +6 more
europepmc +1 more source
Severe Cytokine Release Syndrome After CAR T Cell Therapy in a Pediatric Patient With Relapsed ALL. [PDF]
Alotaibi A, Alajmi N, Alnuhait M.
europepmc +1 more source
Steroid-Refractory Pembrolizumab-Induced Haemophagocytic Lymphohistiocytosis (HLH) Successfully Treated With Anakinra: A Case Report. [PDF]
Kaudlay Sathyanarayana PK +4 more
europepmc +1 more source
Tribulations of Randomized Controlled Trials: Testing the Inflammatory Hypothesis of Heart Failure. [PDF]
Buckley LF, Weber BN.
europepmc +1 more source
Evaluation of the Effect of IL-1 Antagonists on Pituitary Function. [PDF]
Aktas Koc F, Sariakcali B, Sahin A.
europepmc +1 more source
Intra-articular Delivery of Recombinant Interleukin-1 Receptor Antagonist Protein (Anakinra) Enhances Graft Function in a Porcine Model of Osteochondral Repair. [PDF]
Stoeckl BD +13 more
europepmc +1 more source
Mechanistic Insights and Emerging Therapeutic Strategies in Recurrent Pericarditis. [PDF]
Alqahtani MA, Wang TKM, Klein AL.
europepmc +1 more source

